AVGR News and Press, Avinger Inc. From 03/17/24

2024-03-17 08:20:00 ET Wall Street has reached a notable lull in the pace of quarterly releases. Still, investors are eagerly anticipating important announcements from FedEx ( NYSE: FDX ) and a set of prominent consumer brands, such as Nike ( NYSE: NKE ), Lululemon Athl...

REDWOOD CITY, CA / ACCESSWIRE / March 12, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its finan...

2024-03-10 03:55:00 ET Summary Shenzhen EurekaBio closed a $40 million Series B+ funding to support the commercialization of its EuLV™ Lentiviral Vector Production System. Chengdu Maxvax Biotechnology raised $40 million in a Series C financing round to advance its portfolio...

2024-03-08 08:40:50 ET Losers: Amylyx Pharmaceuticals ( AMLX ) -81% as late-stage ALS trial for Relyvrio fails . BigBear.ai Holdings BBAI -20% after Q4 earnings release . AerSale Corp ASLE -20% after Q4 earnings release . OppFi OPFI -17% aft...

2024-03-07 10:24:22 ET DENVER, Colo., Mar 07, 2024 ( 247marketnews.com )- Avinger, Inc. (NASDAQ: AVGR ) stated that it formed a new strategic partnership with Zylox-Tonbridge Medical Tech, a Chinese medical device company AVGR is trading at $3.871, up $0.171 (+4.6216%), on 1,106...

2024-03-07 09:09:27 ET CERo Therapeutics ( CERO ) +625% after announces publication of preclinical research supporting the use of its clinical candidate CER-1236 to treat AML patients . Lytus Technologies ( LYT ) +210% after enters $326 billion data center market...

2024-03-07 01:57:27 ET More on Avinger Seeking Alpha’s Quant Rating on Avinger Historical earnings data for Avinger Financial information for Avinger Read the full article on Seeking Alpha For further details see: Avinger enters partnership...

Initial $7.5 Million Strategic Investment Strategic Partnership Opens Pathway to Access Greater China Market Strengthened Balance Sheet and Three-Year Extension of Existing Debt Terms REDWOOD CITY, CA / ACCESSWIRE / March 6, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage me...

ALL AEGIS CAPITAL CUSTOMERS AND AVINGER INVESTORS SHOULD IMMEDIATELY REVIEW THEIR ACCOUNTS FOR LOSSES NEW YORK, NY / ACCESSWIRE / March 5, 2024 / National investment loss and securities lawyers KlaymanToskes has commenced an investigation into Aegis Capital for their sale and recommendat...

2024-02-21 12:27:34 ET More on Mid-day movers & stocks. Janux Therapeutics: Precision Immunotherapy, But Overpriced For Such An Early Stage Greenbrook TMS secures $1.5M in debt financing Compass Pathways and Greenbrook TMS enter into three-year research collabora...